Literature DB >> 9856355

Angiogenesis and hypertension.

F A le Noble1, F R Stassen, W J Hacking, H A Struijker Boudier.   

Abstract

BACKGROUND: The formation of new blood vessels is an important process in embryonic development and in physiological repair processes. Abnormalities in blood vessel growth have been associated with various pathologies. HYPERTENSION AND IMPAIRED VASCULAR GROWTH: The basic observation underlying the hypothesis that essential hypertension is based on an impaired capacity for vascular growth is the nature of the structural alterations of microvascular beds in essential hypertension. Recent advances in understanding the molecular and cellular mechanisms of vascular growth suggest that the remodeling of individual vessels and vascular networks in hypertension may be a pathological variant of the formation of mature networks. PATHOGENESIS OF IMPAIRED VASCULAR GROWTH: Genetic and fetal influences appear to have significant effects in determining impaired vascular development as an early cause of essential hypertension.

Entities:  

Mesh:

Year:  1998        PMID: 9856355     DOI: 10.1097/00004872-199816110-00001

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  25 in total

1.  Endothelial alpha1-adrenoceptors regulate neo-angiogenesis.

Authors:  M Ciccarelli; G Santulli; A Campanile; G Galasso; P Cervèro; G G Altobelli; V Cimini; L Pastore; F Piscione; B Trimarco; G Iaccarino
Journal:  Br J Pharmacol       Date:  2007-12-17       Impact factor: 8.739

2.  Clinical and genetic correlates of circulating angiopoietin-2 and soluble Tie-2 in the community.

Authors:  Wolfgang Lieb; Justin P Zachariah; Vanessa Xanthakis; Radwan Safa; Ming-Huei Chen; Lisa M Sullivan; Martin G Larson; Holly M Smith; Qiong Yang; Gary F Mitchell; Joseph A Vita; Douglas B Sawyer; Ramachandran S Vasan
Journal:  Circ Cardiovasc Genet       Date:  2010-03-26

3.  Sodium nitrite therapy rescues ischemia-induced neovascularization and blood flow recovery in hypertension.

Authors:  Ali Amin; Soo-Kyoung Choi; Yehia Osman-Elazeik; Nariman K Badr El-Din; Christopher G Kevil; Louis G Navar; Philip Kadowitz; Mohamed Trebak; Khalid Matrougui
Journal:  Pflugers Arch       Date:  2012-10-07       Impact factor: 3.657

4.  Angiogenesis in mesenteric microvascular networks from spontaneously hypertensive versus normotensive rats.

Authors:  Ming Yang; Mario Aragon; Walter L Murfee
Journal:  Microcirculation       Date:  2011-10       Impact factor: 2.628

Review 5.  Role of the Renal Microcirculation in Progression of Chronic Kidney Injury in Obesity.

Authors:  Alejandro R Chade; John E Hall
Journal:  Am J Nephrol       Date:  2016-10-22       Impact factor: 3.754

6.  Significance of microvascular remodelling for the vascular flow reserve in hypertension.

Authors:  Jens Christian Brings Jacobsen; Morten Sonne Hornbech; Niels-Henrik Holstein-Rathlou
Journal:  Interface Focus       Date:  2010-12-01       Impact factor: 3.906

Review 7.  Is endothelial progenitor cell dysfunction involved in altered angiogenic processes in patients with hypertension?

Authors:  Cindy J M Loomans; Huy H Dao; Anton J van Zonneveld; Ton J Rabelink
Journal:  Curr Hypertens Rep       Date:  2004-02       Impact factor: 5.369

8.  The GA genotype of the -1154 G/A (rs1570360) vascular endothelial growth factor (VEGF) is protective against hypertension-related chronic kidney disease incidence.

Authors:  Anna Małkiewicz; Bartosz Słomiński; Maria Skrzypkowska; Janusz Siebert; Piotr Gutknecht; Jolanta Myśliwska
Journal:  Mol Cell Biochem       Date:  2016-06-25       Impact factor: 3.396

Review 9.  Endothelial progenitor cells and their potential clinical implication in cardiovascular disorders.

Authors:  A Zeoli; P Dentelli; M F Brizzi
Journal:  J Endocrinol Invest       Date:  2009-04       Impact factor: 4.256

10.  Characterization of vascular endothelial growth factor receptors on the endothelial cell surface during hypoxia using whole cell binding arrays.

Authors:  Ji Eun Lee; Daniela N Didier; Matthew R Lockett; Mark Scalf; Andrew S Greene; Michael Olivier; Lloyd M Smith
Journal:  Anal Biochem       Date:  2007-06-12       Impact factor: 3.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.